{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:46:41Z","timestamp":1791280001278,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.nano.2015.02.010","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T12:31:09Z","timestamp":1426681869000},"page":"1237-1245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Safe lipid nanocapsule-based gel technology to target lymph nodes and combat mediastinal metastases from an orthotopic non-small-cell lung cancer model in SCID-CB17 mice"],"prefix":"10.1016","volume":"11","author":[{"given":"Nathalie","family":"Wauthoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bastiat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Moysan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cie\u015blak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Zandecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Moal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Rousselet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Hureaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2015.02.010_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.nano.2015.02.010_bb0010","author":"IARC"},{"key":"10.1016\/j.nano.2015.02.010_bb0015","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.nano.2015.02.010_bb0020","series-title":"SEER Cancer Statistic Review, 1975\u20132008","author":"Howlader","year":"2010"},{"key":"10.1016\/j.nano.2015.02.010_bb0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2014.04.051","article-title":"Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers","volume":"193","author":"Ryan","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.02.010_bb0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1378\/chest.08-0978","article-title":"The new lung cancer staging system","volume":"136","author":"Detterbeck","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.nano.2015.02.010_bb0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/1477-3163.105340","article-title":"Hope for progress after 40years of futility? Novel approaches in the treatment of advanced stage III and IV non-small-cell-lung cancer: stereotactic body radiation therapy, mediastinal lymphadenectomy, and novel systemic therapy","volume":"11","author":"Fung","year":"2012","journal-title":"J Carcinog"},{"key":"10.1016\/j.nano.2015.02.010_bb0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000329703","article-title":"Advanced malignant lung disease: what the specialist can offer","volume":"82","author":"Gompelmann","year":"2011","journal-title":"Respiration"},{"key":"10.1016\/j.nano.2015.02.010_bb0045","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4187\/respcare.00947","article-title":"Superior vena cava syndrome in thoracic malignancies","volume":"56","author":"Lepper","year":"2011","journal-title":"Respir Care"},{"key":"10.1016\/j.nano.2015.02.010_bb0050","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2013.08.004","article-title":"PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin","volume":"172","author":"Ryan","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.02.010_bb0055","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1021\/mp300370t","article-title":"Gemcitabine versus modified gemcitabine: a review of several promising chemical modifications","volume":"10","author":"Moysan","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2015.02.010_bb0060","first-page":"209","article-title":"Gemcitabine for the treatment of advanced nonsmall cell lung cancer","volume":"2","author":"Toschi","year":"2009","journal-title":"Oncol Target Ther"},{"key":"10.1016\/j.nano.2015.02.010_bb0065","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1039\/c3sm52781f","article-title":"An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure","volume":"10","author":"Moysan","year":"2014","journal-title":"Soft Matter"},{"key":"10.1016\/j.nano.2015.02.010_bb0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0730-725X(94)00083-F","article-title":"Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties","volume":"13","author":"Trubetskoy","year":"1995","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.nano.2015.02.010_bb0075","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1517\/17425240903085128","article-title":"Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies","volume":"6","author":"Xie","year":"2009","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2015.02.010_bb0080","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4161\/cbt.7.5.5721","article-title":"Chemotherapy targeting regional lymphatic tissues to treat rabbits bearing VX2 tumor in the mammary glands","volume":"7","author":"Chen","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.nano.2015.02.010_bb0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0169-409X(01)00154-5","article-title":"Liposomes to target the lymphatics by subcutaneous administration","volume":"50","author":"Oussoren","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.02.010_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0169-409X(00)00121-6","article-title":"Lymphatic targeting with nanoparticulate system","volume":"47","author":"Nishioka","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.02.010_bb0095","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.addr.2011.05.016","article-title":"Targeting the lymphatics using dendritic polymers (dendrimers)","volume":"63","author":"Kaminskas","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.02.010_bb0100","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0003-4975(00)01144-9","article-title":"Artificial lymphogenous metastatic model using orthotopic implantation of human lung cancer","volume":"69","author":"Ishikura","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.nano.2015.02.010_bb0105","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1023\/A:1016121319668","article-title":"A novel phase inversion-based process for the preparation of lipid nanocarriers","volume":"19","author":"Heurtault","year":"2002","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2015.02.010_bb0110","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1023\/A:1010931127745","article-title":"Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery","volume":"18","author":"Calvo","year":"2001","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2015.02.010_bb0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jconrel.2008.05.027","article-title":"Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas","volume":"130","author":"Allard","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.02.010_bb0120","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s11095-006-0022-2","article-title":"Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules","volume":"23","author":"Peltier","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2015.02.010_bb0125","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.nano.2012.08.005","article-title":"Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models","volume":"9","author":"Hirsjarvi","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2015.02.010_bb0130","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1016\/j.actbio.2013.01.038","article-title":"Surface modification of lipid nanocapsules with polysaccharides: from physicochemical characteristics to in vivo aspects","volume":"9","author":"Hirsjarvi","year":"2013","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2015.02.010_bb0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijpharm.2011.06.031","article-title":"In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse model","volume":"423","author":"David","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2015.02.010_bb0140","doi-asserted-by":"crossref","first-page":"054005","DOI":"10.1117\/1.3213606","article-title":"Cyanine-loaded lipid nanoparticles for improved in vivo fluorescence imaging","volume":"14","author":"Texier","year":"2009","journal-title":"J Biomed Opt"},{"key":"10.1016\/j.nano.2015.02.010_bb0145","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jconrel.2013.06.014","article-title":"A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging","volume":"170","author":"Bastiat","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.02.010_bb0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jim.2006.01.022","article-title":"Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in BALB\/cAnNCrl mice","volume":"312","author":"Van den Broeck","year":"2006","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.nano.2015.02.010_bb0155","author":"Gemcitabine"},{"key":"10.1016\/j.nano.2015.02.010_bb0160","first-page":"464","article-title":"Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms","volume":"120","author":"Custer","year":"1985","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nano.2015.02.010_bb0165","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijpharm.2013.05.057","article-title":"Effect of particle size on the biodistribution of lipid nanocapsules: comparison between nuclear and fluorescence imaging and counting","volume":"453","author":"Hirsjarvi","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2015.02.010_bb0170","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2217\/nnm.11.141","article-title":"Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming","volume":"6","author":"Wang","year":"2011","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2015.02.010_bb0175","first-page":"719","article-title":"Green fluorescent protein expression and visualization of mediastinal lymph node metastasis of human lung cancer cell line using orthotopic implantation","volume":"24","author":"Ishikura","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/j.nano.2015.02.010_bb0180","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1158\/1535-7163.MCT-05-0031","article-title":"Matrix metalloproteinase inhibitor MMI-166 inhibits lymphogenous metastasis in an orthotopically implanted model of lung cancer","volume":"4","author":"Fujino","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.nano.2015.02.010_bb0185","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.breast.2009.05.004","article-title":"Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet)","volume":"18","author":"Leonard","year":"2009","journal-title":"Breast"},{"key":"10.1016\/j.nano.2015.02.010_bb0190","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.addr.2007.08.044","article-title":"Protein nanoparticles as drug carriers in clinical medicine","volume":"60","author":"Hawkins","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.02.010_bb0195","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri2017","article-title":"Humanized mice in translational biomedical research","volume":"7","author":"Shultz","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2015.02.010_bb0200","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3626","article-title":"The secret ally: immunostimulation by anticancer drugs","volume":"11","author":"Galluzzi","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2015.02.010_bb0205","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00262-013-1407-9","article-title":"Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma","volume":"62","author":"Ghansah","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.nano.2015.02.010_bb0210","first-page":"795","article-title":"A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients","volume":"24","author":"Yanagimoto","year":"2010","journal-title":"Oncol Rep"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996341500060X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996341500060X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T04:51:16Z","timestamp":1537764676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154996341500060X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S154996341500060X"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2015.02.010","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safe lipid nanocapsule-based gel technology to target lymph nodes and combat mediastinal metastases from an orthotopic non-small-cell lung cancer model in SCID-CB17 mice","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2015.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}